National Center for Toxicological Research

The biggest federal lab in Arkansas sets the FDA gold standard. Cuts threaten its standing. read more >

About 75 employees at the National Center for Toxicological Research near Pine Bluff are losing their positions or being placed on leave. read more >

One goal of program's goals is to help the state avoid the duplication of research dollars. read more >

Jerry Adams, president of the Arkansas Research Alliance, announced this week the promotion of Bryan Barnhouse to CEO. read more >

Gov. Asa Hutchinson this week, along with FDA leadership and other elected officials, cut the ribbon on the renovated Building 14 at the FDA’s National Center for Toxicological Research in Jefferson County. read more >

Spektron Systems of Little Rock is using artificial intelligence and machine learning to speed up drug discovery in a process that involves designing a new molecule that could be further developed into a new drug. read more >

CEO Roger Williams says Energy Security Partners has selected land in Jefferson County as its final and official site for a $3 billion-plus plant to convert natural gas into diesel and other liquid fuels. Williams said the final piece of the puzzle was acquisition of an easement allowing river access. read more >

Arkansas has signed a memorandum of understanding to extend its partnership with the U.S. Food & Drug Administration's National Center for Toxicological Research (NCTR) in Jefferson County. read more >

In pursuing plans for a natural gas-to-liquid fuel production facility, Energy Security Partners of Little Rock spent more than a year securing the land for its likely plant site in northern Jefferson County. read more >

Tell Roger Williams that a multibillion-dollar plant for turning natural gas into liquid fuel near Pine Bluff sounds too good to be true, and he’ll turn to history, engineering and finance to argue it’s too good not to be. read more >

The Arkansas Research Alliance announced Wednesday that it has been awarded a $1.2 million contract from the U.S. Food and Drug Administration that will extend a collaborative research program focused on graphene-based nanomaterials. read more >

Brian Umberson, spokesman for Bio+Nano+Arkansas, says Arkansas boasts a "surprising assortment" of biotech and nanotech companies that provide research-based services related to cell lines, diagnostics and raw materials. read more >